Articles published in Journal of Vaccines & Vaccination have been cited by esteemed scholars and scientists all around the world. Journal of Vaccines & Vaccination has got h-index 24, which means every article in Journal of Vaccines & Vaccination has got 24 average citations.
Following are the list of articles that have cited the articles published in Journal of Vaccines & Vaccination.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
67 | 60 | 59 | 65 | 71 | 11 | 19 | 26 | 45 | 44 | 52 | 59 | 54 | 13 | 14 |
Research, Review articles and Editorials |
14 | 14 | 19 | 41 | 29 | 11 | 15 | 16 | 17 | 34 | 40 | 42 | 38 | 10 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
38 | 46 | 40 | 30 | 42 | 0 | 4 | 10 | 28 | 10 | 12 | 17 | 21 | 3 | 4 |
Conference proceedings |
18 | 8 | 32 | 23 | 0 | 0 | 112 | 104 | 154 | 315 | 180 | 116 | 110 | 122 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
121 | 206 | 193 | 258 | 232 | 212 | 200 | 205 | 224 | 245 | 110 | 61 | 22 | 20 | 0 |
Journal total citations count | 2341 |
Journal impact factor | 2.87 |
Journal 5 years impact factor | 3.73 |
Journal cite score | 4.69 |
Journal h-index | 24 |
A Scoping Review of Investment Cases for Vaccines and Immunization Programs
????????????????? ????? ??????????????? ??????? ?????? ?????? ????????? ?? ?????? ???????????? ???
Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines
Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector
High-throughput screening for negative-stranded hemorrhagic fever viruses using reverse genetics.
Recombinant attenuated Mopeia virus comprising a modified nucleoprotein with reduced exonuclease activity
Arenavirus Quasispecies and Their Biological Implications.
Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.
Vaccine platforms to control Lassa fever
Lassa virus diversity and feasibility for universal prophylactic vaccine.
Genetic Variation In Vitro and In Vivo of an Attenuated Lassa Vaccine Candidate
The search for animal models for Lassa fever vaccine development
A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever
South American Hemorrhagic Fevers: a summary for clinicians
Vaccines for viral hemorrhagic fevers--progress and shortcomings
Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.
RESEARCH AND REVIEWS: JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY Novel Aspects and Strategies in Vaccination
Novel Aspects and Strategies in Vaccination
Insight into the Intermolecular Recognition Mechanism between HLA-A*24:02 and Antitumor Peptides against Breast Cancer
The Effect of Peptide Treatment on the HLA-Binding and Antibody Production in Peripheral Blood Mononuclear Cells Obtained from Japanese Breast Cancer Patients